Literature DB >> 15058201

Levels of apolipoprotein A-II in cerebrospinal fluid in patients with neuroborreliosis are associated with lipophagocytosis.

L Táborský1, P Adam, O Sobek, M Dostál, J Dvoráková, L Dubská.   

Abstract

Levels of most of the examined proteins in cerebrospinal fluid (CSF) of 107 patients with neuroborreliosis were associated with cytological findings, the status of hematoencephalic barrier as evaluated by Qalb (cerebrospinal fluid to serum quotient) and the intrathecal synthesis of immunoglobulins. Cytological findings consisted of normal cytology, or both oligocytosis and pleocytosis of monocytes or lymphocytes. The lipophagic elements were present in 20% of samples. Concentrations of apolipoproteins A-I and A-II in the CSF were correlated with the concentration of albumin without regard to the CSF cytology. The levels of apolipoprotein B were increased only in samples with lymphocytic pleocytosis and Qalb > 7.4. The presence of lipophages in the CSF was significantly associated with the CSF concentration of apolipoprotein A-II.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15058201     DOI: 10.1007/bf02931523

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  35 in total

1.  Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases.

Authors:  H Reiber
Journal:  J Neurol Sci       Date:  1994-04       Impact factor: 3.181

2.  Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes.

Authors:  G W Rebeck; N C Alonzo; O Berezovska; S D Harr; R B Knowles; J H Growdon; B T Hyman; A J Mendez
Journal:  Exp Neurol       Date:  1998-01       Impact factor: 5.330

Review 3.  Lipoproteins in the central nervous system.

Authors:  M J Ladu; C Reardon; L Van Eldik; A M Fagan; G Bu; D Holtzman; G S Getz
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

4.  Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid.

Authors:  J Carlsson; V W Armstrong; H Reiber; K Felgenhauer; D Seidel
Journal:  Clin Chim Acta       Date:  1991-02-15       Impact factor: 3.786

5.  Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.

Authors:  G Salen; V Berginer; V Shore; I Horak; E Horak; G S Tint; S Shefer
Journal:  N Engl J Med       Date:  1987-05-14       Impact factor: 91.245

6.  Apolipoprotein E and multiple sclerosis: a biochemical and genetic investigation.

Authors:  O Gaillard; A Gervais; D Meillet; E Plassart; B Fontaine; O Lyon-Caen; J Delattre; E Schuller
Journal:  J Neurol Sci       Date:  1998-06-30       Impact factor: 3.181

7.  Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.

Authors:  K Blennow; C Hesse; P Fredman
Journal:  Neuroreport       Date:  1994-12-20       Impact factor: 1.837

8.  Apolipoprotein A-II gene and development of amyloidosis and senescence in a congenic strain of mice carrying amyloidogenic ApoA-II.

Authors:  K Higuchi; H Naiki; K Kitagawa; H Kitado; K Kogishi; T Matsushita; T Takeda
Journal:  Lab Invest       Date:  1995-01       Impact factor: 5.662

9.  Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis.

Authors:  H Tumani; G Nölker; H Reiber
Journal:  Neurology       Date:  1995-09       Impact factor: 9.910

10.  Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin.

Authors:  N A Elshourbagy; M S Boguski; W S Liao; L S Jefferson; J I Gordon; J M Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

View more
  6 in total

1.  Critical evaluation of the biological role of IgM in cerebrospinal fluid in inflammatory and other diseases of the nervous system.

Authors:  J Svatonová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

2.  Cerebrospinal-fluid profile in neuroborreliosis and its diagnostic significance.

Authors:  J Bednárova
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

3.  Improved method of detection and molecular typing of Borrelia burgdorferi sensu lato in clinical samples by polymerase chain reaction without DNA purification.

Authors:  N Rudenko; M Golovchenko; J Nemec; J Volkaert; N Mallátová; L Grubhoffer
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

4.  Immunochemical analysis of lipopolysaccharide-like component extracted from Borrelia burgdorferi sensu lato.

Authors:  K Schwarzová; I Ciznár
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

5.  Cytomorphologic Features Found in Cerebrospinal Fluid Specimens of Hemophagocytic Lymphohistiocytosis Patients.

Authors:  Susan Shyu; Dragos Luca; Christopher J VandenBussche; Cheng-Ying Ho
Journal:  Am J Clin Pathol       Date:  2021-08-04       Impact factor: 2.493

6.  Analysis of cerebrospinal fluid cell populations with monoclonal antibodies.

Authors:  P Adam; O Sobeka; C S Scott
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.